Understanding the emergence of the tobacco industry's use of the term tobacco harm reduction in order to inform public health policy

Silvy Peeters, Anna B. Gilmore

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objectives: To explore the history of transnational tobacco companies’ use of the term, approach to and perceived benefits of ‘harm reduction’.

Methods: Analysis of internal tobacco industry documents, contemporary tobacco industry literature and 6 semistructured interviews.

Results: The 2001 Institute of Medicine report on tobacco harm reduction appears to have been pivotal in shaping industry discourse. Documents suggest British American Tobacco and Philip Morris International adopted the term ‘harm reduction’ from Institute of Medicine, then proceeded to heavily emphasise the term in their corporate messaging. Documents and interviews suggest harm reduction offered the tobacco industry two main benefits: an opportunity to (re-) establish dialogue with and access to policy makers, scientists and public health groups and to secure reputational benefits via an emerging corporate social responsibility agenda.

Conclusions: Transnational tobacco companies’ harm reduction discourse should be seen as opportunistic tactical adaptation to policy change rather than a genuine commitment to harm reduction. Care should be taken that this does not undermine gains hitherto secured in efforts to reduce the ability of the tobacco industry to inappropriately influence policy.
LanguageEnglish
Pages182-189
JournalTobacco Control
Volume24
Issue number2
Early online date22 Jan 2014
DOIs
StatusPublished - Apr 2015

Fingerprint

Tobacco Industry
Harm Reduction
Tobacco Use
Public Policy
Health Policy
health policy
nicotine
Tobacco
Public Health
public health
industry
National Academies of Science, Engineering, and Medicine (U.S.) Health and Medicine Division
Interviews
Aptitude
Social Responsibility
medicine
Administrative Personnel
discourse
Industry
social responsibility

Keywords

  • tobacco industry
  • harm reduction
  • snus
  • public health policy

Cite this

Understanding the emergence of the tobacco industry's use of the term tobacco harm reduction in order to inform public health policy. / Peeters, Silvy; Gilmore, Anna B.

In: Tobacco Control, Vol. 24, No. 2, 04.2015, p. 182-189.

Research output: Contribution to journalArticle

@article{26a40d445a3b48e6ab07901b84133360,
title = "Understanding the emergence of the tobacco industry's use of the term tobacco harm reduction in order to inform public health policy",
abstract = "Objectives: To explore the history of transnational tobacco companies’ use of the term, approach to and perceived benefits of ‘harm reduction’. Methods: Analysis of internal tobacco industry documents, contemporary tobacco industry literature and 6 semistructured interviews. Results: The 2001 Institute of Medicine report on tobacco harm reduction appears to have been pivotal in shaping industry discourse. Documents suggest British American Tobacco and Philip Morris International adopted the term ‘harm reduction’ from Institute of Medicine, then proceeded to heavily emphasise the term in their corporate messaging. Documents and interviews suggest harm reduction offered the tobacco industry two main benefits: an opportunity to (re-) establish dialogue with and access to policy makers, scientists and public health groups and to secure reputational benefits via an emerging corporate social responsibility agenda. Conclusions: Transnational tobacco companies’ harm reduction discourse should be seen as opportunistic tactical adaptation to policy change rather than a genuine commitment to harm reduction. Care should be taken that this does not undermine gains hitherto secured in efforts to reduce the ability of the tobacco industry to inappropriately influence policy.",
keywords = "tobacco industry, harm reduction, snus, public health policy",
author = "Silvy Peeters and Gilmore, {Anna B.}",
year = "2015",
month = "4",
doi = "10.1136/tobaccocontrol-2013-051502",
language = "English",
volume = "24",
pages = "182--189",
journal = "Tobacco Control",
issn = "1468-3318",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Understanding the emergence of the tobacco industry's use of the term tobacco harm reduction in order to inform public health policy

AU - Peeters, Silvy

AU - Gilmore, Anna B.

PY - 2015/4

Y1 - 2015/4

N2 - Objectives: To explore the history of transnational tobacco companies’ use of the term, approach to and perceived benefits of ‘harm reduction’. Methods: Analysis of internal tobacco industry documents, contemporary tobacco industry literature and 6 semistructured interviews. Results: The 2001 Institute of Medicine report on tobacco harm reduction appears to have been pivotal in shaping industry discourse. Documents suggest British American Tobacco and Philip Morris International adopted the term ‘harm reduction’ from Institute of Medicine, then proceeded to heavily emphasise the term in their corporate messaging. Documents and interviews suggest harm reduction offered the tobacco industry two main benefits: an opportunity to (re-) establish dialogue with and access to policy makers, scientists and public health groups and to secure reputational benefits via an emerging corporate social responsibility agenda. Conclusions: Transnational tobacco companies’ harm reduction discourse should be seen as opportunistic tactical adaptation to policy change rather than a genuine commitment to harm reduction. Care should be taken that this does not undermine gains hitherto secured in efforts to reduce the ability of the tobacco industry to inappropriately influence policy.

AB - Objectives: To explore the history of transnational tobacco companies’ use of the term, approach to and perceived benefits of ‘harm reduction’. Methods: Analysis of internal tobacco industry documents, contemporary tobacco industry literature and 6 semistructured interviews. Results: The 2001 Institute of Medicine report on tobacco harm reduction appears to have been pivotal in shaping industry discourse. Documents suggest British American Tobacco and Philip Morris International adopted the term ‘harm reduction’ from Institute of Medicine, then proceeded to heavily emphasise the term in their corporate messaging. Documents and interviews suggest harm reduction offered the tobacco industry two main benefits: an opportunity to (re-) establish dialogue with and access to policy makers, scientists and public health groups and to secure reputational benefits via an emerging corporate social responsibility agenda. Conclusions: Transnational tobacco companies’ harm reduction discourse should be seen as opportunistic tactical adaptation to policy change rather than a genuine commitment to harm reduction. Care should be taken that this does not undermine gains hitherto secured in efforts to reduce the ability of the tobacco industry to inappropriately influence policy.

KW - tobacco industry

KW - harm reduction

KW - snus

KW - public health policy

UR - http://www.scopus.com/inward/record.url?scp=84892731166&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1136/tobaccocontrol-2013-051502

U2 - 10.1136/tobaccocontrol-2013-051502

DO - 10.1136/tobaccocontrol-2013-051502

M3 - Article

VL - 24

SP - 182

EP - 189

JO - Tobacco Control

T2 - Tobacco Control

JF - Tobacco Control

SN - 1468-3318

IS - 2

ER -